ARTICLE | Clinical News
Gilenia fingolimod regulatory update
March 1, 2010 8:00 AM UTC
FDA accepted for filing and granted Priority Review to an NDA from Novartis for Gilenia fingolimod to treat multiple sclerosis (MS). Novartis, which said the agency is likely to schedule an advisory c...